chr12-77029908-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_203394.3(E2F7):āc.1807C>Gā(p.Gln603Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000942 in 1,614,124 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_203394.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
E2F7 | NM_203394.3 | c.1807C>G | p.Gln603Glu | missense_variant | 10/13 | ENST00000322886.12 | |
E2F7 | XM_011537966.3 | c.1672C>G | p.Gln558Glu | missense_variant | 9/12 | ||
E2F7 | XM_011537969.3 | c.1504C>G | p.Gln502Glu | missense_variant | 9/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
E2F7 | ENST00000322886.12 | c.1807C>G | p.Gln603Glu | missense_variant | 10/13 | 1 | NM_203394.3 | P1 | |
E2F7 | ENST00000550669.5 | c.1807C>G | p.Gln603Glu | missense_variant | 10/11 | 1 | |||
E2F7 | ENST00000416496.6 | c.1807C>G | p.Gln603Glu | missense_variant | 10/12 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152232Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251406Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135884
GnomAD4 exome AF: 0.000101 AC: 147AN: 1461892Hom.: 0 Cov.: 31 AF XY: 0.0000935 AC XY: 68AN XY: 727246
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152232Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74378
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | The c.1807C>G (p.Q603E) alteration is located in exon 10 (coding exon 9) of the E2F7 gene. This alteration results from a C to G substitution at nucleotide position 1807, causing the glutamine (Q) at amino acid position 603 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at